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ABSTRACT 
Dandruff, also known as seborrhea sicca, pityriasis capitis or sicca capitis, can be defined as 
chronic non-inflammatory scaling of the scalp, or an abnormality in the desquamation process 
which occurs on the scalp (Willet, 2010). It is said that dandruff affects at least 50% of the 
world’s adult population and about 15 – 20% of the world’s total population (Prambhamanju 
et al., 2009).  
 
Aim: To ascertain the effect of sodium shale oil sulphonate 1% shampoo on the appearance of 
dandruff. Forty participants completed the study and participants were of both genders between 
the ages of 18 and 45. The study compromised of 16 days with 3 visits each 8 days apart. 
 
Methodology: The study design consisted of double-blind, placebo-controlled study where 
participants were grouped into matching pairs based on the severity of the condition. 
Participants were then randomly assigned to the treatment or placebo group. At each visit, 
participants were assessed using the following assessment measures: a Visual Analogue Scale 
for the participant comprising of scaling, irritation, itching, greasiness and global impression; 
a Visual Analogue Scale for the researcher comprising of scaling, irritation, greasiness and 
global impression as well as an Adherent Scalp Flake Score grading completed by the 
researcher. 
 
Results: Parametric and non-parametric analyses were used and the results of the study 
demonstrated overall statistically significant improvement in all parameters for the treatment 
and placebo groups but the extent of improvement was greater in the treatment group.  
However, at individual visits, only certain parameters expressed statistically significant 
changes when compared to the placebo group. 
 
Conclusion: It was found that both Sodium Shale Oil Sulphonate 1% shampoo and the control 
shampoo may contribute significantly to the improvement of the appearance of dandruff with 
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respect to all of the aforementioned parameters. No significant difference was found between 
the sodium shale oil sulphonate 1% shampoo and the control shampoo relevant to irritation, 
itching, greasiness or researcher global impression. 
 
The Sodium Shale Oil Sulphonate 1% shampoo was shown to yield a higher percentage 
improvement for each measured parameter than the control substance and showed a significant 
improvement over and above the control shampoo with respect to only the following 
parameters: scaling (participant rated p=0.012; researcher rated p=0.020) and the global 
impression (participant rated p=0.048). Higher numbers of participants and longer study 
periods are however required to verify these results. 
 
INTRODUCTION 
Dandruff, also known as Pityriasis capitis, is a common condition affecting the scalp. It is 
estimated that dandruff affects at least 50% of the world’s adult population and about 15 – 20% 
of the world’s total population (Nowicki, 2006). Dandruff is caused by increased desquamation 
and cell growth leading to irritation, marked by flaking and itching of the scalp with associated   
greasiness (Roger, 2010). Although dandruff is not a cause of major morbidity, as it only affects 
the scalp, it may be embarrassing and distressing to sufferers leading to low self-esteem and 
social problems (Nowicki, 2006). The psychological effects of dandruff warrants research into 
ways in which the problem can be addressed. 
 
Current treatment options for dandruff include many over-the-counter preparations, anti-
dandruff shampoos and topical steroid medications. These treatments may be accompanied by 
side effects and possible aggravation of the condition.  Some commonly used ingredients have 
carcinogenic properties, while others cause increased irritability, dryness and itching of the 
scalp, allergic reactions (contact dermatitis), endocrine and epithelial cell disruptions, and 
headaches (Pierard–Franchimont et al., 2001). Options available for the treatment of dandruff 
are not always effective and can pose the risk of higher recurrence rates. Some only provide 
symptomatic relief for the condition and include numerous harmful side effects as 
aforementioned. 
 
Ichthyol® Pale shampoo is a sodium salt of pale sulphonated shale oil in aqueous solution. It 
has anti-microbial, anti-inflammatory, anti-seborrheic and anti-fungal properties. It combats 
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dandruff by means of slowing down the desquamation process and regulating cell growth, thus 
addressing both the cause and symptoms of dandruff (Lunar Pharmaceuticals, 2014). Research 
on Ichthyol® Pale  needs to be conducted in order to evaluate its effect on the treatment of 
dandruff, as no external research has been done to date.  
 
The use of Sodium Shale Oil Sulphonate 1% shampoo may provide a long term, safer and more 
effective treatment option for dandruff. Should the study produce positive results, further 
research on the treatment of dandruff, and other similar conditions, using Shale Oil Sulphonate 
1% shampoo can be conducted.   
 
SUMMARY OF LITERATURE REVIEW 
Structure of the Skin   
The skin is the largest organ of the entire human body. Tissues that make up the skin constantly 
grow, differentiate and renew themselves. The skin acts as a major protection barrier between 
the internal and external environment (Hull, 2011).  
 
The skin is made up of 3 layers – the epidermis (external layer), the dermis (internal layer), and 
the subcutaneous tissue – together with blood vessels, nerves and accessory structures (hair, 
nails and sweat glands)  (Hall and Hall, 2010). The skin itself, together with accessory 
structures, makes up the integumentary system. As with other systems of the body, the 
integumentary system does not function in isolation. It depends largely on an extensive network 
of blood vessels as well as sensory receptors in order to complete its functions (Martini and 
Nath, 2009). 
 
Dandruff 
The word pityriasis capitis (dandruff), introduced to the world of dermatology by Galen, 
originates from the Greek word ‘pityriasis’ which means bran-like (Rastegar, 2009). Dandruff, 
also known as seborrhea sicca, pityriasis capitis or sicca capitis, can be defined as chronic 
non-inflammatory scaling of the scalp, or an abnormality in the desquamation process which 
occurs on the scalp. Scaling often occurs on the epidermal layer of the skin and can affect 
individuals to varying degrees (Willet, 2010). The presenting white flakes of dandruff can be 
constant, recurrent or sporadic and can vary in severity (Pierard–Franchimont et al., 2001). 
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Two types of dandruff are thought to exist: Common or dry dandruff and oily dandruff 
(Adamski, 2006). 
 
 
Epidemiology 
Dandruff is an age-related condition. It is rarely seen prior to puberty, increases in occurrence 
in post pubertal individuals, peaks in the early twenties, and declines in frequency in 
individuals over 50 years. According to American market research, at least 80-90% of people 
suffer from some type of scaling disorder. Of that, 30-35% of those suffer from dandruff 
(Robbins, 2012). In terms of the world adult population, at least 50% suffer from dandruff 
contributing to approximately 15-25% of the total population (Prambhamanju et al., 2009). 
According to extrapolated statistics of the United States, approximately 8 million South 
Africans suffer from dandruff (Pray, 2006).  
 
Aetiology 
Since the 19th century, many different causes for dandruff have been proposed. Through the 
years, these propositions have been further studied in order to pin point a single cause of 
dandruff. The aetiologic factors involved in causing dandruff can be described as multi-
factorial, and includes any combination of the Malassezia fungus, lipase activity, presence of 
sebum, lipid levels as well as other factors such as stress, immune function, genetic 
susceptibility and humidity (Schwarts, 2003).    
 
Signs and Symptoms  
Dandruff is characterized by loosely adherent small white-grey flakes. The flakes are generally 
noticeable to the sufferer when brushing or combing the hair or on the shoulder area when dark 
colour clothing is worn (Sage, 2005). 
 
Scaling may be accompanied by itching of the scalp, irritation and also possible hair loss. In 
rare cases, the skin can also become reddened with greasy patches and minute openings on the 
scalp that may ooze a yellow liquid which later forms crusts (Jacoby and Moungson, 2005).  
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Differential Diagnosis 
Many different conditions are commonly confused with dandruff as they share similar 
symptoms as the condition. Conditions that are often wrongly diagnosed include psoriasis, 
Tinea capitis, atopic eczema, allergic contact dermatitis, head lice and dry scalp (Thomas et al., 
2001; Sage, 2005; Hall and Hall, 2010)  
 
Dandruff Severity Measures 
The modified Visual Analogue Scale (VAS) is a subjective measure which can be used to 
evaluate the symptoms of dandruff including: scaling, irritation, greasiness and itching, as well 
the psychological effect of dandruff on the participant, termed ‘global impression’ (Stubbs et 
al., 2000). 
 
According to Baran and Maibach (1998), the Adherent Scalp Flake Score (ASFS) grading is 
the primary measure used in many anti-dandruff trials. It is based on an 11 point scale of 
flaking, ranging from 0 to 10 where 0 reveals no scaling and 10 reveals very heavy scaling. 
The scalp can be divided into either 6 or 8 sections or anatomic sites on the scalp. The hair in 
each section is parted in order to visualize the severity of the flaking in that particular atomic 
site on the scalp. Each section is scored from 0 to 10. The scores are then added to give a total 
score out of 60 or 80 depending on the amount of sections examined. This evaluation method 
can be used effectively to observe the condition over time (Schwarts, 2012).  
 
Conventional Treatment 
Treatment options for dandruff may be topical in the form of creams, ointment or shampoos, 
or they can be taken orally (Gupta et al., 2004). The Consensus of the Expert Group of Polish 
Dermatological Society Mycological Section has summarized and codified the 
pharmacological treatment of dandruff. Based on the mechanism of action, anti-dandruff 
formulas can be classified into three groups - fungicidal substances, cytostatic substances and 
keratolytic substances - each with specific common active ingredients (Adamski, 2006). Anti 
– inflammatory substances are also commonly used for the treatment of dandruff.  
 
Sodium Shale Oil Sulphonate/Pale Sulfonated Shale Oil Shampoo 
Sodium shale oil sulphonate 1% shampoo, trading as Ichthyol® Pale, is manufactured in 
Germany, and distributed in South Africa by Lunar Pharmaceuticals. Ichthyol® Pale is a 
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sodium shale oil sulphonate which originates from keragon-containing sedimentary rock. 
Through the process of distillation, the keragon rock produces a sulphur-rich shale oil which 
is purified, refined and neutralized before use (Lunar Pharmaceuticals, 2014). Sodium shale 
oil sulphonate may be used for the treatment of dandruff, as well as for skin complaints such 
as acne and blemishes (Sanders, 2008).  
According to the literature, pale sulphonated shale oil has widespread dermatological uses as 
it is believed to have anti-inflammatory, anti-microbial and anti-seborrheic properties (Lunar 
Pharmaceutics, 2014). Based on its actions, pale sulphonated shale oil can be used for the 
following: 
1. Conditions with overproduction of the oil glands such as acne; 
2. Bacterial and fungal infections; 
3. Inflammatory conditions such as seborrheic dermatitis, atopic dermatitis and psoriasis; 
4. Conditions of excess desquamation such as dandruff; 
5. Venous leg ulcers; and  
6. Wound healing (Willet, 2010). 
 
METHODOLOGY  
Research Sample  
A representative sample of 40 participants, suffering from mild to moderate dandruff, were 
recruited for the study via advertisements. The sample included both males and females 
between the ages of 18 and 45 years. Advertisements were placed at the University of 
Johannesburg Health Training Centre notice boards and restrooms, as well as in gyms and hair 
salons in and around the South of Johannesburg with relevant permission. 
 
Inclusion Criteria 
Participants were included if they were: Males and females between the ages of 18 to 45 years; 
suffering from mild to moderate dandruff with itching, flaking, greasiness, irritation of the 
scalp and possible hair loss (Kent, 2005); had a baseline Adherent Scalp Flaking Score grading 
ASFS score of ≥ 24; and had good general health. 
 
Exclusion Criteria 
Participants were excluded if they were: Suffering from other conditions such as psoriasis, 
atopic dermatitis, contact dermatitis or tinea capitis; diagnosed with systemic or chronic 
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diseases; pregnant or lactating; currently on any chronic medication; and/or currently on 
treatment for dandruff. 
 
Participants were requested to refrain from using any conventional, herbal or homeopathic 
treatment for dandruff for the duration of the study. Only Sodium Shale Oil Sulfonate 1% 
shampoo was used as treatment. 
 
3.2 Research Procedure and Design 
The research study was performed as a 16-day double-blind, placebo-controlled study design. 
The research was conducted at the University of Johannesburg, Doornfontein Campus. The 
initial consult (day zero) consisted of a full description and discussion of the research method 
with the participant. Thereafter, the participant was requested to read a participant information 
form and sign a consent form. An evaluation based on the inclusion and exclusion criteria, to 
determine whether the participant met the criteria for the research study, was performed. A 
physical and general assessment was conducted to determine vital signs and health status 
respectively. Thereafter, the participant’s dandruff was evaluated using the Adherent Scalp 
Flaking Score (ASFS) grading, completed by the researcher, and the Visual Analogue Scale 
(VAS), completed by both the participant and the researcher. The participants were divided 
into two groups by means of matched pairing, according to the severity of dandruff of their 
dandruff. Based on the determined group, the participants were given either the experimental 
(with active anti-dandruff agents) or control (without active anti-dandruff agents) shampoo 
together with the directions for the use of the shampoo. At the second consultation, which 
occurred on day 8, the participant’s scalp was evaluated using the ASFS grading, completed 
by the researcher, and the VAS, completed by the participant and the researcher. On day 16 
(final consult), a final evaluation of the participant’s dandruff was performed, using the same 
method described as with the second consult. At each consult, all results were recorded. 
Participants were requested to wash the scalp once every second day, starting from day one till 
day 16. Reminders to wash the scalp were sent to each participant via SMS the night before 
they were due to wash their hair. 
 
Medication administration  
Each participant was given 200 ml of either Sodium Shale Oil Sulphonate 1% shampoo or 
placebo shampoo for use over 16 days. Participants were requested to wash the scalp once 
every second day (day 1, 3, 5, 7, 9, 11, 13, 15). Each time the scalp was washed, the participant 
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was instructed to use only 25ml of the shampoo which was measured out using a standard 
25ml measuring cup supplied. No other shampoo was used for the duration of the research. 
 
Sodium Shale Oil Sulphonate 1% 
Each bottle of the shampoo using the trade name Ichthyol Pale® contained 1% of Sodium Shale 
Oil Sulphonate as the active anti-dandruff ingredient. The shampoo was produced by Lunar 
Pharmaceutics which is a registered pharmaceutical company that maintains good 
manufacturing procedures and is registered with the Pharmacy Council of South Africa. The 
shampoo was produced, packaged and labelled by Lunar Pharmaceutics. The labels consisted 
of the numbers ‘1’ and ‘2’ to ensure that neither the participant nor the researcher was aware 
of which batch contained the active ingredient and which batch contained the placebo. This 
was only determined at the end of the study. The control shampoo was manufactured to look 
and feel the same as the experimental shampoo but without the active anti-dandruff ingredient, 
sodium shale oil sulphonate. The participants were given a particular bottle using matched 
pairing according to the severity of the dandruff, to ensure a parametric distribution of the 
participants across the two groups.   
 
Reliability and validity measures 
The Adherent Scalp Flake Score (ASFS) grading is one of the best methods for the assessment 
of seborrheic dermatitis and dandruff as validated by various research trials and practice 
(Bacon, 2012). It is also used in private practice by dermatologists to evaluate the extent of 
such conditions (Schwarts, 2012).  
 
The Visual Analogue Scale (VAS) is the most commonly used scale of measure in terms of 
healthcare research (Johnson, 1997). Both self-perception and clinical assessment using VAS 
is regarded as a valid subjective measure for participant’s evaluation of dandruff, as it exhibits 
a rational degree of reliability (Stubbs et al., 2000) 
 
Ethics 
All information regarding procedures, duration and requirements of the study was provided 
and explained to the participants as per the participant information form. In order to participate 
in the study all participants were requested to sign the participant consent form. All 
participation in the study was voluntary and withdrawal from the study could take place at any 
time. There were no anticipated risk factors to the use of the shampoo. However, participants 
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were advised to discontinue the shampoo if any adverse reactions occurred and to contact the 
researcher. Privacy and confidentiality of the participant was guaranteed by providing private 
consultations with the researcher, and all information will be kept in a secure storage facility 
for five years to which only the researcher and supervisor has access to. Anonymity was upheld 
by replacing the use of participant names in the research with case numbers. Researcher and 
supervisor contact details were made available to the participants should any further questions 
arise. In the event that results were requested by the participant, they were made available. In 
case of any unforeseen circumstances or outcomes, participants were referred to the relevant 
healthcare practitioner. In the case of favourable data in the experimental Group as compared 
to the control Group, the participants in the control Group were provided access to the shampoo 
at the end of the study. This study was approved by the University of Johannesburg, Faculty of 
Health Sciences Higher Degrees and Research Ethics committees.  
 
RESULTS 
On completion of the study, Lunar Pharmaceutics disclosed the ingredients in the bottles 
labelled ‘1’ and ‘2’ for the purpose of the researcher to determine which participants were in 
the control and experimental groups. All data was collated and an Exploratory Data Analysis 
(EDA) was performed to determine group normality and comparability of the data. The Shapiro 
– Wilk test was performed to assess the normality of the data. Thereafter, parametric or non – 
parametric tests were employed based on normality. Parametric intergroup analysis included 
the independent sample T- test, followed by intragroup analysis using the repeated measures 
ANOVA test. Non-parametric intergroup analysis included the Mann-Whitney U test, while 
intragroup analysis involved the Friedman or the Wilcoxon Signed-Ranks test (Van Staden, 
2014). 
 
A total of 42 participants were assessed for eligibility from which none were excluded as they 
all met the participation requirements and were included to participate in the study. Of the 42 
participants, 18 were given the active shampoo and 24 were given the placebo shampoo 
randomly based on matched pairing on the basis of the severity of their dandruff. One 
participant was lost from group 1 (treatment group) and one participant was also lost from 
group 2 (control group). Therefore, 17 participants were analysed in group 1 and 23 participants 
were analysed in group 1. 
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Data collected for scaling was normally distributed according to the Shapiro Wilk test allowing 
for parametric data analysis. All other variables showed an abnormal distribution of data, 
therefore non-parametric tests were used in order to analyse the data. 
 
A total of 40 participants completed the study. Of the 40 participants, most of which were from 
Indian race, 33 (82.5%) were females and 7 (17.5%) were males. With respect to age, all 
participants were aged between 18 and 45 years. The ages between the participants were 
comparable as the p value was 0.161 and there is no statistical significance in the age between 
the two groups.   
 
Comparability was reported with respect to primary visit scores for all the parameters assessed 
by both the participant and the researcher.  
 
Scaling  
Over the duration of the study, the scaling in the treatment group was found to improve by 
76.9% (p = <0.001), and by 45.1% in Group 2 (p = <0.001) when considering the participant 
evaluation. Despite significant improvements for both groups over the course of the study, it 
was revealed that there was still a significant difference (p = 0.012) between the groups at the 
last visit (visit 3). Since both groups had comparable degrees of scaling at visit 1, this result 
suggests that both groups experienced improvement with respect to the appearance of scaling, 
but that the treatment group (Group 1) appeared to gain a more significant improvement. 
 
With respect to the same criteria using the researcher evaluation, a similar trend was observed 
where an overall improvement of 64.6% in scaling occurred in Group 1 (p = <0.001) whereas 
Group 2 showed an improvement of only 43% (p = <0.001). Although both groups showed 
significant improvements during the study, a statistically significant difference (p = 0.019) was 
found at visit 3 between the two groups. At visit 1 both groups were comparable with regards 
to scaling therefore, similar to the participant evaluations, there was a greater improvement in 
the appearance of scaling for Group 1 when compared to Group 2.  
 
Irritation  
For Group 1, irritation (scored by the participant) improved by a total of 74.8% (p = <0.001), 
whereas for Group 2, a total of 52.8% improvement occurred (p = <0.001). Groups 1 and 2 
both demonstrated a statistically significant improvement, which shows that both groups 
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improved significantly in the scores for irritation. However, despite the improvement of both 
groups there was shown to be no statistically significant difference between the two groups at 
visit 2 and 3 (p = 0.697 and p = 0.249).  
 
When scored by the researcher, the total improvement for irritation improved in Group 1 by 
78.8% (p = 0.001) and in Group 2 by 77.3% (p = <0.001). There was found to be no statistical 
significance in irritation between the two groups at visit 2 and 3 (p = 0.483 and 0.412, 
respectively).  
 
Itching 
Although both Group 1 and 2 displayed statistically significant improvements in itching, Group 
1 (76.8%) had a higher overall improvement when compared to group 2 (54.7%). The p value 
for Group 1 was <0.001 similar to <0.001 of Group 2 indicating that both the treatment and 
placebo shampoo assisted in significantly reducing the presence of itching on the scalp.  
 
Group 1 and 2 were comparable at visit 1 and by visit 2 and 3, there still appeared to be no 
statistical significance (p = 0.418 and 0.749 respectively) in the presence of itching. 
 
Greasiness  
Both Group 1 and 2 had a total improvement for greasiness according to the participant 
evaluations. Group 1 improved by 79.3% (p= <0.001) compared to group 2 with a 61.2% (p = 
0.001) improvement. Both groups yielded a p value of <0.05 indicating a statistically 
significant change in greasiness over the period of the study. This indicates that both shampoos 
produced similar results with regards to greasiness. Similar to visits 1, no statistically 
significant difference occurred between Group 1 and 2 by visit 2 and 3 (p = 0.468 and 0.115 
respectively).  
 
Overall improvements for greasiness were present in the researcher results for Group 1 with an 
80.5% (p = 0.001) improvement and Group 2 with a 74% (p = <0.001) improvement. Similar 
to the participant evaluations, no statistically significant differences occurred between the 2 
groups at visit 2 and 3 (p = 0.141 and 0.307 respectively) 
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Global impression  
The overall participant global impression rating for both groups showed significant 
improvements for Group 1 of 65% (p = 0.001). On the other hand, Group 2 showed less than 
half the improvement of Group 1 (30.6%) with no statistical significance (p = 0.033).  
 
Both groups were comparable with respect to global impression at visit 1. On the contrary, at 
visit 3 significant differences (p = 0.048) in the average global impression occurred between 
the 2 groups.  
 
As indicated in the researcher results, Group 1 produced an overall average improvement of 
56% (p = 0.001) whereas Group 2 produced an overall improvement of 42.2% (p = 0.002) in 
global impression. Although both groups showed improvements, at visit 3 (p = 0.209), no 
significant difference was found between the 2 groups contrary to the results obtained in the 
participant evaluation. 
 
When compared, the results obtained from the ratings for global impression indicate that the 
participant evaluations showed a greater improvement than the researcher evaluations. 
 
Adherent Scalp Flake Score grading  
According to the results, it is indicated that both groups 1 and 2 showed significant 
improvements of 67.9% (p = <0.001) and 50.6% (p = <0.001) respectively in the ASFS grading 
over the period of the study.  
 
At visit 1 there appeared to be no statistically significant difference for the inter group analysis 
as both groups were comparable with regards to ASFS grading. However, at visit 3, as indicated 
in the results the p value was 0.035 indicating a statistically significant difference in the mean 
ASFS of the 2 groups.  
 
DISCUSSION  
Results obtained displayed changes in both groups with regards to scaling. However, the 
significant change in scaling for the treatment group may be explained by the presence of the 
active ingredient – which is reported to successfully treat scaling and desquamation disorders 
(Willet, 2010) - in the shampoo. A standard protocol was employed with respect to the 
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frequency of hair washes. Although the control group showed changes in scaling, such changes 
were not statistically significant but the increased frequency of hair washes may provide an 
understanding as to why the control group showed a decrease in scaling as well (Gerson, 2004). 
 
Changes in irritation were reported for both the treatment and control group, such changes may 
be explained by the presence of certain ingredients in the shampoo which provide relief from 
irritation (Barel et al., 2010) as well as the presence of sodium shale oil sulphonate in the 
treatment shampoo which has been reported to possess anti-inflammatory properties (Willet, 
2010).  
 
Similar changes in itching were noted for the treatment and control group. Ingredients such as 
sodium shale oil sulphonate, found in the treatment shampoo, as well as sweet almond 
amphoacetate, found in both the treatment and control shampoo, both contain anti-fungal 
properties (Brown, 2010 and Willet, 2010). Almost all fungal infections are characterised by 
the presence of itching (Hall and Hall, 2010), the presence of anti-fungal ingredients in both 
the treatment and control shampoo may explain why the treatment and control shampoo 
performed similarly with respect to itching.  
 
The results reported for greasiness can be explained by the increased frequency of washing 
(Gerson, 2004) which controls greasiness of the scalp. Usage of styling products – which may 
contribute significantly to greasiness of the scalp (Ahmed et al., 2007) - was prohibited during 
the course of the study which may also explain the decrease in the greasiness for both the 
treatment and control group. 
 
According to Sage (2005), the psychological effects of dandruff are noteworthy due to the 
increased concern in society regarding appearance. The most visible symptom of dandruff is 
the presence of flakes or scaling either on the scalp or over the shoulders. Therefore, the 
significant change in global impression may be explained by the significant change in scaling 
reported previously. However, the researcher and participant evaluation seemed to differ as a 
significant change was only reported by the participant evaluations. Such a result may be 
explained by the greater social impact of the condition on the sufferer when compared to the 
view of an outsider viz. the researcher in this case. 
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The ASFS grading results, assessed by the researcher, displayed significant changes in favour 
of the treatment group. This result may also be explained by the significant change in scaling 
reported above. The increased frequency of washing which removes excess sebum 
accumulation (Nina, 2013) may provide an explanation as to the decrease in scaling which 
consequently results in a decreased ASFS grading.  
 
CONCLUSION 
It was found that both sodium shale oil sulphonate 1% shampoo and the control shampoo may 
contribute significantly to the improvement of the appearance of dandruff with respect to all of 
the aforementioned parameters. No significant difference was found between the sodium shale 
oil sulphonate 1% shampoo and the control shampoo relevant to irritation, itching, greasiness 
or researcher global impression. 
 
The sodium shale oil sulphonate 1% shampoo was shown to yield a higher percentage 
improvement for each measured parameter than the control substance and showed a significant 
improvement over and above the control shampoo with respect to only the following 
parameters: scaling (participant rated p = 0.012; researcher rated p = 0.020) and the global 
impression (participant rated p = 0.048). Comparable to the results presented for scaling, 
significant changes in ASFS grading occurred overall at visit 3 for the sodium shale oil 
sulphonate 1% (67.9%) versus the control shampoo (50.6%) (p = 0.035).  Higher numbers of 
participants and longer study periods are however required to verify these results. 
 
The improvements in scaling, significant global impression recorded by the participant and 
ASFS grading reported by the researcher could imply that sodium shale oil sulphonate 1% 
shampoo may decrease the appearance of scaling in a relatively short period of time (16 days). 
Wide scale research and further verification of these is mandated prior to the finalisation of any 
claim of beneficial improvement. 
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